UBS Reiterates Neutral Rating on Carter's (CRI), Expects Solid Q1 Results
UBS analyst Jay Sole reiterated a Neutral rating and $40.00 price target on Carter's (NYSE: CRI).The analyst commented, "Our checks ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)